회사 소개
- 법인명: Croda pharma
- 등록 국가: United Kingdom
- 주소: Cowick, Snaith, East Cowick, Goole
- 직원 수: 1000 - 4999
설명:
Croda Pharma is a leading partner for developing excipients and supplying high-purity materials for pharmaceutical formulations, offering high-purity excipients that enhance delivery, efficacy and stability of active ingredients, along with high-performing vaccine adjuvants and in-house formulation expertise to navigate drug and vaccine formulation challenges. The company focuses on enabling biologics drug delivery through its adjuvant systems and small molecule, protein and nucleic acid delivery platforms, offering solutions for both human and animal health markets backed by substantial investment in GMP and multi-site EXCiPACT accreditation.
사업 활동
부형제 & 첨가제
제조업체위탁제조업체 (CMO)부형제 공급업체
천연추출물 & 생약원료
제조업체위탁제조업체 (CMO)부형제 공급업체
제약용 화학물질
제조업체위탁제조업체 (CMO)부형제 공급업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
주요 제품/서비스
- 계약 및 아웃소싱 서비스: Adjuvant Systems for Vaccines
- 부형제 & 첨가제: Excipient: Super Refined™ PEG 400, Excipient: Super Refined™ Polysorbate 80, Excipient: Super Refined™ Polysorbate 20, Excipient: Super Refined™ DEGEE, Excipient: Super Refined™ P35 Caster Oil, Tween™ 80 HP, Super Refined™ PGML, Cholesterol, Crodafos™ CES pharma, Super Refined™ GMCC, Super Refined™ L18 POG, Super Refined™ O18 POG, Excipients for Consumer Health, Super Refined™ Benzyl Alcohol, Super Refined™ DMI, Super Refined™ GTCC, Super Refined™ PEG 300
- 제약용 화학물질: Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics
- 바이오의약품: Cationic Adjuvant Formulation CAF®
- 바이오의약품 서비스: Bioprocessing solutions and excipients for protein therapeutic formulations
- ATC 분류체계 (해부치료화학분류): ALC-0315
- 오리지널 원료의약품: ENT-DSPC, Vaccine Adjuvant: Alhydrogel™, Vaccine Adjuvant: Quil-A™
당사 제품 & 서비스
Sell · ATC (Anatomical Therapeutic Chemical) Classification
인증
GMP
증거
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기